Drugs for the management of rheumatoid arthritis : clinical evaluation / George A. Wells, Christine Smith, Alomgir Hossain, Jacob Karsh, Jasvinder Singh, Glen Hazlewood, Peter Tugwell
The objective of this review is to assess the benefits and harms of drugs used in adult patients with moderate to severe rheumatoid arthritis (RA) in whom treatment with methotrexate (MTX) has failed or who are intolerant to MTX..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
March 2018 |
|---|---|
| Erschienen: |
Ottawa: CADTH ; March 2018 |
| Reihe: |
CADTH health technology assessment - issue 146 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wells, George A. [VerfasserIn] |
|---|
| Links: |
www.ncbi.nlm.nih.gov [teilw. kostenfrei] |
|---|
| Themen: |
Antirheumatic Agents |
|---|
| Anmerkungen: |
Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed January 7, 2019) |
|---|
| Umfang: |
1 online resource (1 PDF file (207 pages)) ; illustrations. |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
1773195794 |
|---|
| LEADER | 01000cam a22002652 4500 | ||
|---|---|---|---|
| 001 | 1773195794 | ||
| 003 | DE-627 | ||
| 005 | 20230428012030.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211011s2018 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1773195794 | ||
| 035 | |a (DE-599)KEP068696515 | ||
| 035 | |a (NCBI)9917377113406676 | ||
| 035 | |a (EBP)068696515 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wells, George A. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Drugs for the management of rheumatoid arthritis |b clinical evaluation |c George A. Wells, Christine Smith, Alomgir Hossain, Jacob Karsh, Jasvinder Singh, Glen Hazlewood, Peter Tugwell |
| 264 | 1 | |a Ottawa |b CADTH |c March 2018 | |
| 300 | |a 1 online resource (1 PDF file (207 pages)) |b illustrations. | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a CADTH health technology assessment |v issue 146 | |
| 500 | |a Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed January 7, 2019) | ||
| 520 | |a The objective of this review is to assess the benefits and harms of drugs used in adult patients with moderate to severe rheumatoid arthritis (RA) in whom treatment with methotrexate (MTX) has failed or who are intolerant to MTX. | ||
| 650 | 2 | |a Antirheumatic Agents |x therapeutic use |0 https://id.nlm.nih.gov/mesh/D018501Q000627 | |
| 650 | 2 | |a Arthritis, Rheumatoid |x drug therapy |0 https://id.nlm.nih.gov/mesh/D001172Q000188 | |
| 650 | 2 | |a Comparative Effectiveness Research |0 https://id.nlm.nih.gov/mesh/D057186 | |
| 655 | 2 | |a Review |0 https://id.nlm.nih.gov/mesh/D016454 | |
| 655 | 2 | |a Tables |0 https://id.nlm.nih.gov/mesh/D020501 | |
| 710 | 2 | |a Canadian Agency for Drugs and Technologies in Health, |e MitwirkendeR |4 ctb | |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/books/NBK532102/ |m X:NCBI |x Verlag |z teilw. kostenfrei |
| 912 | |a ZDB-193-NCB | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a ISIL_DE-18 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_22_i06404 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a ISIL_DE-7 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a ISIL_DE-354 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a ISIL_DE-25 | ||
| 912 | |a GBV_ILN_2009 | ||
| 912 | |a ISIL_DE-180 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a ISIL_DE-15 | ||
| 951 | |a BO | ||
| 980 | |2 22 |1 01 |x 0018 |b 3994092558 |h h64 NCBI |y zi06404 |z 21-10-21 | ||
| 980 | |2 40 |1 01 |x 0007 |b 3994018838 |h OLR-NCB-BOOKSHELF |y xsn |z 21-10-21 | ||
| 980 | |2 74 |1 01 |x 0354 |b 3999795425 |c 09 |f E-Bibl |d EM 0000 |e --%%-- |j --%%-- |y ze |z 08-11-21 | ||
| 980 | |2 2003 |1 01 |x DE-25 |b 3995683622 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Open Access |y l01 |z 25-10-21 | ||
| 980 | |2 2009 |1 01 |x DE-180 |b 3987685700 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 11-10-21 | ||
| 980 | |2 2010 |1 01 |x DE-15 |b 3987770198 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Open Access |y l01 |z 11-10-21 | ||
| 981 | |2 22 |1 01 |x 0018 |r https://www.ncbi.nlm.nih.gov/books/NBK532102/ | ||
| 981 | |2 40 |1 01 |x 0007 |y Volltext, Open Access |r https://www.ncbi.nlm.nih.gov/books/NBK532102/ | ||
| 981 | |2 74 |1 01 |x 0354 |r https://www.ncbi.nlm.nih.gov/books/NBK532102/ | ||
| 981 | |2 2003 |1 01 |x DE-25 |r https://www.ncbi.nlm.nih.gov/books/NBK532102/ | ||
| 981 | |2 2010 |1 01 |x DE-15 |y Online-Zugriff |r https://www.ncbi.nlm.nih.gov/books/NBK532102/ | ||
| 985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
| 985 | |2 74 |1 01 |x 0354 |a EM 0000 | ||
| 995 | |2 22 |1 01 |x 0018 |a h64 NCBI | ||
| 995 | |2 22 |1 01 |x 0018 |a h64 freie Ressource | ||
| 995 | |2 40 |1 01 |x 0007 |a OLR-NCB-BOOKSHELF | ||